MedBlogs

FDA Warning On Diabetes Drug Rosiglitazone

Posted by Dr.Trupti on Thu, 14 Oct 2010

(0) No of Views (5207)

Member SignIn
Please login to rate

Email
Password


Forgot Password? Sign up now

0 rating

There has been concerns about the safety of diabetic drugs containing rosiglitazone. Rosiglitazone is a thiazolidinedione antidiabetic agent used in conjunction with diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Majority members of the advisory committee set up by the FDA found a significant cause for concern because of increase in ischemic cardiovascular events with rosiglitazone relative to pioglitazone. In clinical trials conducted by the FDA in 2007 i... Read More

Share this MedBlog

Tags :

Post Your Comments

This is an open forum for the public. Please follow our Community Guidelines when posting any material. You are welcome to be critical or controversial, but avoid getting personal, abusive or offensive and try to keep your postings brief. All postings are being constantly reviewed for spam and irrelevant material (such as product advertisement or personal advertisements). Any posting that does not conform to our policy and 'Terms of Use' are deleted.
Remember threads are for only feedback and discussion. We will not use this material for publishing papers or advertisements.
You need to be registered with Medwonders to post any item. If you are a New User please register. You will be re-directed back to this page.